Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Promising phase I/II data for 81C6 pave the way for phase III trials in brain tumor patients

April 22, 1999

Favorable efficacy and safety profile of CEP-701 in PDAC

April 22, 1999

PNU-159548 undergoes phase I trials; preclinical results presented at AACR meeting

April 22, 1999

Efficacy of IL-2 Gene Medicine is enhanced by combination with chemotherapeutic agent

April 22, 1999

GnRH pharmaccine reduces testosterone to castration levels

April 22, 1999

Small peptide from Angstrom highly active against human breast tumor xenografts

April 21, 1999

Sanofi and Lilly to jointly develop oxaliplatin in U.S.

April 21, 1999

SQ-885: a specific angiogenesis inhibitor and integrin antagonist

April 21, 1999

Immunomedics clones RNase and prepares RNase-containing anticancer fusion protein

April 21, 1999

Targretin as novel therapy for refractory breast cancer: preclinical studies

April 21, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 12, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...